Three Democratic senators, including Elizabeth Warren, Jacky Rosen, and John Hickenlooper, have jointly advised the Federal Reserve to decrease its benchmark interest rate. This recommendation stems from their observation that the prevailing high interest rate is compounding inflationary pressures rather than alleviating them. The senators directed their letter to Federal Reserve Chairman Jerome Powell, emphasizing the necessity for an urgent reduction in the federal funds rate, which currently stands at 5.5%, marking a peak over the past two decades. They voiced their concerns about the adverse effects of prolonged high interest rates on economic growth and inflation. Furthermore, the senators pinpointed the repercussions on sectors such as housing, construction, and auto insurance costs, warning about the potential recessionary impact and employment losses that could ensue. Drawing parallels with recent rate cuts by the European Central Bank and the Bank of Canada, the senators urged the Fed to reconsider its inflation target and align with the changing global economic landscape.
Democratic Senators' Plea for Federal Reserve to Lower Interest Rate Amid Inflation Concerns

by Giorgi Kostiuk
2 years ago

Other news
Beware of Scams in C2C Crypto Trading

C2C trading exposes users to several common scams, including fake payment proofs and chargeback fraud. Traders must be vigilant and adopt security measures to protect their assets from these fraudulent tactics.

Ethereum Trading Indicators Show Mixed Signals

Current technical analysis of Ethereum reveals mixed signals, with the MACD indicating bearish momentum while the Chaikin Money Flow suggests strong buying pressure.

Knightsbridge Savings Announces Improved Investment Rates for 2026

Knightsbridge Savings announces improved investment rates for 2026, offering enhanced options for both entry-level and high-end investors.

Converge Bio's AI Platform Aims to Transform Drug Development

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

Buterin Continues Charity Donations from Token Sales

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

Be the first to know about crypto news every day
Get crypto analysis, news and updates right to your inbox! Sign up here so you don’t miss a single newsletter